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Varicocele is one of the most common causes of low semen quality, which is reflected in high percentages of sperm cells with
fragmented DNA.While varicocelectomy is usually performed to ameliorate a patient’s fertility, its impact on spermDNA integrity
in the case of subclinical varicocele is poorly documented. In this study, multiple DNA fragmentation analyses (TUNEL, SCD, and
SCSA) were performed on semen samples from sixty infertile patients with varicocele (15 clinical varicoceles, 19 clinical varicoceles
after surgical treatment, 16 subclinical varicoceles, and 10 subclinical varicoceles after surgical treatment). TUNEL, SCD, and SCSA
assays all showed substantial sperm DNA fragmentation levels that were comparable between subclinical and clinical varicocele
patients. Importantly, varicocelectomy did improve sperm quality in patients with clinical varicocele; however, this was not the case
in patients with subclinical varicocele. In summary, although infertile patients with clinical and subclinical varicocele have similar
sperm DNA quality, varicocelectomy should only be advised for patients with clinical varicocele.
1. Introduction
One of the main causes of male infertility stems from a
series of abnormally dilated veins in the pampiniform plexus,
commonly called varicocele. Its presence and severity are
often associated with impaired spermatogenesis and poor
sperm quality [1]. Varicocele incidence has been estimated to
be 21%–41% in the infertile male population [2, 3]. Concern-
ing its diagnosis, clinical varicocele is determined according
to the Dubin grading system during physical examination,
while subclinical varicocele is typically detected by scrotal
Doppler ultrasonography [4, 5]. Distinction between clinical
and subclinical varicoceles is important, as urologists must
choose the most suitable (surgical) method depending on
the patient’s clinical state to improve fertility [6]. This is
not an easy task, particularly in the case of subclinical
varicocele. Not only is there a lack of data about subclinical
varicocele on sperm parameters, but also surgical treatment
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of subclinical varicocele is currently debated, as contradictory
postoperative results are being reported [7].
As a measure of sperm quality, sperm DNA fragmen-
tation (SDF) has experienced a growing interest in recent
years [8]. Sperm DNA damage is now linked to longer
conception times [9], higher miscarriage rates [10, 11], and
even severe childhood diseases such as cancer or neurological
disorders [12]. Mainmechanisms of SDF in the sperm cell are
nuclease activation in an apoptotic-like process and oxidative
stress associated with a defective maturation and nuclear
protamination [13, 14]. Typically, high percentages of sperm
cells with fragmented DNA are found in varicocele patients
[15, 16]. Surgical treatment is reported to improve SDF levels
[17, 18]; however there is a lack of information about sperm
DNA integrity in subclinical varicocele as well as conflicting
results about the impact of vein repair [7].
The objective of this study was therefore to characterize
the degree of spermDNA fragmentation using three different
methodological approaches in four cohorts of infertile males:
(i) clinical varicocele without varicocelectomy, (ii) clinical
varicocele after varicocelectomy, (iii) subclinical varicocele
without varicocelectomy, and (iv) subclinical varicocele after
varicocelectomy.
2. Materials and Methods
2.1. Selection of Patients. The study included a total of 60
infertile males with varicocele who were classified in four
different cohorts. The first cohort included 15 males with
nontreated grade I clinical varicocele (CV), the second group
included 16 males with subclinical varicocele diagnosed by
scrotal Doppler ultrasonography (ScV), the third cohort
included 19 patients with surgically treated clinical varicocele
(T-CV), and the last cohort included 10 patients with sur-
gically treated subclinical varicocele (T-ScV). Samples from
surgical treated patients were obtained 6 to 12 months after
the varicocelectomies were performed (Buntz method). The
age of all donors ranged from 25 to 35 years. Patients with
genitourinary inflammation, leukocytospermia, or altered
hormonal profiles were excluded from the study. Written
informed consent was obtained from all patients and the
Institutional Ethics Committee approved the study.
2.2. Sample Collection. Semen samples were obtained by
masturbation after three days of sexual abstinence. Prior to
cryopreservation, fresh ejaculatewas allowed to liquefy.Then,
samples were mixed 1 : 1 with cryopreservation medium (14%
glycerol, 30% egg yolk, 1.98% glucose, and 1.72% of sodium
citrate), aliquoted and incubated at −80∘C in an isopropanol
bath overnight, and then plunged into liquid nitrogen until
the experiment was performed. For analysis, all samples were
thawed by immersion in a 37∘C water bath for 30 seconds
andwashed three times with PBS buffer at room temperature,
and the sperm concentration was adjusted according to the
requirements for TUNEL [20], SCD [21], and SCSA [22].
2.3. Terminal Transferase dUTP Nick-End Labeling (TUNEL)
Assay. For the TUNEL assay, the in situ cell-death detection
kit (Roche Diagnostic GmbH, Penzberg, Germany) was used
as previously described [20]. This assay quantifies, by flow
cytometry or fluorescent microscopy, the incorporation of
labeled deoxyuridine triphosphate (dUTP) at the sites of
DNA breaks in a reaction catalyzed by the deoxynucleotidyl
transferase enzyme. Semen samples were washed twice in
PBS and the concentration was adjusted to 10 × 106 cells/mL.
200𝜇L of this sperm suspension was fixed in an equal
volume of 4% (w/v) paraformaldehyde for 1 hour at room
temperature and then washed in PBS supplemented with 1%
(v/v) bovine serum albumin (BSA; Sigma Chemicals). Sperm
cells were permeabilized using 0.1% (v/v) TritonX-100 in 0.1%
(w/v) sodium citrate for 2min on ice and then washed twice
in PBS supplemented with 1% BSA. The pellet was incubated
in 50 𝜇L of a mix containing 45𝜇L of the label solution
plus 5𝜇L of the terminal deoxynucleotidyl transferase (TdT)
enzyme for 1 hour at 37∘C in the dark. The sample was then
washed twice using 1% BSA in PBS. The negative control was
incubated without the TdT enzyme and the positive control
was prepared before the labeling reaction with an additional
treatment withDNase I (RocheDiagnostic GmbH, Penzberg,
Germany), 100 IU, for 10min at 37∘C. In order to perform
flow cytometry analysis, the final pellet from the sperm
sample was resuspended in a final volume of 1mL PBS. Green
fluorescence (TUNEL-positive cells) was measured using a
530 nm ± 30 nm band-pass filter. A total of 10,000 events
were measured at a flow rate of 200–300 cells/s on a flow
cytometer (FACSCalibur, Becton Dickinson, NJ, USA). Data
were processed by CELLQUEST analysis software (Becton
Dickinson).
2.4. Sperm Chromatin Dispersion Test (SCD). For the SCD
test, the Halosperm kit was used (Chromacell SL, Madrid,
Spain). It is based on the principle that sperm with frag-
mented DNA fails to produce the characteristic halo of dis-
persedDNA loops that is observed in healthy nonfragmented
sperm DNA [21]. The semen samples were washed twice in
PBS and the concentration was adjusted to 5 × 106 cells/mL.
Low-melting-point agarose was melted in a water bath at
90∘C–100∘C for 5min and then placed in water at 37∘C for
5min. 60 𝜇L of the semen sample was then mixed with
agarose and 20 𝜇L of the semen-agarosemixture was pipetted
onto an agarose-coated slide, covered with a coverslip and
left at 4∘C for 5min. The coverslip was gently removed
and the slide was immersed in an acid solution for 7min,
washed for 5min with distilled water, and incubated in 10mL
of the lysing solution for 25min. After washing, the slides
were dehydrated in 70%, 90%, and 100% ethanol for 2min
each and then air-dried. Slides were stained for bright-field
microscopy using Diff-Quick (2𝜇g/mL) (Panreac, Barcelona,
Spain) according to manufacturer’s instructions. 300 sper-
matozoa were scored and the proportion of sperm with
fragmented DNA was expressed as % SDF.
2.5. Sperm Chromatin Structure Assay (SCSA). SCSA proto-
col has been described elsewhere [22]. Briefly, an aliquot of
the thawed semen sample was diluted to a concentration of
2 × 106 sperm/mL in TNE buffer (0.15M NaCl, 0.01M Tris,
BioMed Research International 3
and 1mM EDTA, pH 7.4) to a total of 200𝜇L. Thereafter,
400 𝜇L of acid detergent solution (0.08M HCl, 0.15M NaCl,
and 0.1% Triton X-100, pH 1.2) was added. After 30 s, sperm
cells were stained by adding acridine orange (AO) staining
solution (Life Sciences, Oregon, USA), containing 6𝜇g AO
permL buffer (0.037M citric acid, 0.126MNa
2
HPO
4
, 1.1 mM
EDTA, and 0.15MNaCl, pH 6.0). After 3min staining, a total
of 5,000 sperm cells were analyzed by flow cytometry (FAC-
SCalibur, Becton Dickinson, NJ, USA). The percentage of
sperm with DNA fragmentation was determined in the main
sperm population and detected as increased red fluorescent
signal compared to intact sperm DNA fluorescence.
2.6. Statistical Analysis. Data analysis was performed using
the Statistics Package for the Social Sciences software, version
15 (SPSS Inc., Chicago, IL). SDF values were compared using
the Mann-Whitney 𝑈 test. Correlations were studied using
the Spearman test. The level of significance was established
at 95% of the confidence interval in order to be considered
statistically significant.
3. Results
3.1. Multiple Determination of Sperm DNA Fragmentation.
SDF values of each patient as determined by TUNEL, SCSA,
and SCD are depicted in Figure 1. Median and range of
SDF values obtained for all patient groups are shown in
Table 1. Clinical and subclinical varicocele groups without
varicocelectomy (i.e., CV versus ScV) displayed substantial
sperm DNA damage regardless of the method of analysis
used. Patients with clinical varicocele that had undergone
varicocelectomy showed significant lower SDF values com-
pared to the untreated group (i.e., T-CV versus CV), in both
SCD (𝑃 < 0.05) and SCSA assays (𝑃 < 0.05), but fail-ed to
reach significance in the TUNEL assay (𝑃 = 0.09). How-
ever, in patients with subclinical varicocele, no benefit of
varicocelectomy on SDF values was found by any of the
methods (i.e., ScV versus T-ScV).
3.2. Correlation Analysis. A good correlation amongst the
three methods to determine sperm DNA damage was
observed. Values were 𝑟 = 0.703 (𝑃 < 0.001) for TUNEL ver-
sus SCSA, 𝑟 = 0.568 (𝑃 < 0.001) for TUNEL versus SCD, and
𝑟 = 0.662 (𝑃 < 0.001) for SCSA versus SCD.
4. Discussion
In this work we attempted to answer three questions. (i) Are
TUNEL, SCD, and SCSA assays equally suited to determine
spermDNAdamage in varicocele patients? (ii) Is spermDNA
quality comparable between infertile patients with clinical
varicocele or subclinical varicocele? (iii) Does varicocelec-
tomy improve sperm DNA quality in clinical and subclinical
varicocele patients?
Currently, there is a debate about whether the various
methods available to determine the degree of sperm DNA
fragmentation offer the same guarantees of sensitivity and
specificity [12, 19]. One issue is the occurrence of apoptotic
bodies which, due to their similar forward scatter/side scatter
properties as sperm cells, complicate the interpretation of
results in the TUNEL assay [24]. In addition, the presence of
these apoptotic bodies is especially common in patients with
asthenoteratozoospermia, such as varicocele patients [25]. It
is therefore likely that our results obtained by TUNEL were
biased by this phenomenon, which is substantiated by the
higher correlation rates we observed in a previous studywhen
using fertile subjects with normal seminal parameters [26]. In
consequence, apoptotic bodies must be taken into account in
cytometric assays, such as TUNEL, particularly in the case
of varicocele patients. Regarding the sensitivity of TUNEL,
SCD, and SCSA, continuous efforts are being exerted to
optimize these methods. More recently, it is even possible
to determine whether DNA damage is single-stranded or
double-stranded by alkaline and neutral comet assays [27,
28].
Nevertheless, our TUNEL, SCD, and SCSA analyses
unequivocally showed that infertile patients with diagnosed
subclinical varicocele have similar (poor) spermDNAquality
as infertile patients with clinical varicocele (Figure 1). In
addition, significant amounts of highlyDNAdegraded sperm
(DDS) were encountered in both patient groups (Table 1).
This sperm subpopulation, which is defined by massive
protein depletion andDNAdamage, typically constitutes 1%–
4% of healthy semen. In contrast, up to eightfold higher
DDS levels are characteristic of patients with varicocele, even
when compared to other infertile males [23, 27]. These high
DDS levels in subclinical and clinical varicocele would imply
a similar negative impact for these groups of patients on
spermatogenesis and a corresponding difficulty in achieving
pregnancy.
The last point of interest is the putative beneficial effect
of surgical treatment by the Buntz method varicocelectomy
on sperm DNA quality. Operated patients with clinical
varicocele displayed significantly lower SDF levels compared
to the untreated group (Table 1), which is in line with
previous studies reporting increased sperm DNA quality and
improved pregnancy rates [29–31]. In contrast, we observed
no benefit of varicocelectomy on SDF values in patients
with subclinical varicocele. One plausible explanation for this
discrepancy is the difficulty for the surgeon to specifically
target the affected veins. Despite the fact that both types
of varicocele have substantial SDF levels and thus would
require the same treatment, results obtained in this work
indicate that varicocelectomy of subclinical varicocele does
not confer any amelioration. Varicocelectomy by the Buntz
method should therefore be counterindicated in patients
with subclinical varicocele. A promising alternative is the
microsurgical varicocelectomy, performed by a subinguinal
or inguinal incision [32]. Recent studies show that better
results are obtained by microsurgical varicocelectomy [6]
and in particular that sperm DNA quality is ameliorated in
patients with clinical varicocele [17, 18, 33]. The next step
would therefore be to assess the efficacy of microsurgical
varicocelectomy in the case of subclinical varicocele.
In conclusion, using multiple sperm DNA determination
methods we showed (i) that clinical and subclinical varico-
celes have a similar negative effect on sperm DNA integrity
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Figure 1: Sperm DNA fragmentation (SDF) values as determined by terminal transferase dUTP nick-end labeling (TUNEL) (a), sperm
chromatin structure assay (SCSA) (b), and sperm chromatin dispersion (SCD) (c) assays. CV, nontreated grade I clinical varicocele; T-CV,
surgically treated clinical varicocele; ScV, nontreated subclinical varicocele; T-ScV, surgically treated subclinical varicocele. Horizontal bars
represent median SDF values. ∗𝑃 < 0.05; §data of fertile donors from [19].
Table 1: Multiple determination of sperm DNA fragmentation (SDF) in infertile males with nontreated grade I clinical varicocele (CV),
surgically treated clinical varicocele (T-CV), nontreated subclinical varicocele (ScV), and surgically treated subclinical varicocele (T-ScV).
Highly DNA degraded sperm (DDS) was also measured by the sperm chromatin dispersion (SCD) assay. Median SDF values are given and
ranges are bracketed. Pairwise comparisons were performed using the Mann-Whitney 𝑈 test.
Type of SDF assay CV(𝑛 = 15)
T-CV
(𝑛 = 19)
ScV
(𝑛 = 16)
T-ScV
(𝑛 = 10)
Fertile
(𝑛 = 21)
TUNEL (%) 31.60(16.79–67.71)
23.65
(12.68–37.22)
31.38
(17.99–74.10)
28.95
(11.06–53.65)
13.14
§
(6.59–29.33)
SCSA (%) 22.11(9.98–53.88)
14.39∗
(7.70–32.19)
21.30
(12.94–74.48)
26.12
(8.99–68.77)
12.00
§
(5.00–27.31)
SCD (%) 30.50(17.00–50.00)
23.00∗
(11.00–39.00)
37.75
(19.50–78.00)
29.00
(24.00–70.00)
12.00
§
(4.00–20.80)
DDS (by SCD) (%) 17.00(5.50–30.00)
13.00
(6.00–22.50)
19.50
(11.50–37.00)
17.25
(10.00–30.00)
1.20#
(0.00–4.50)
∗
𝑃 < 0.05.
§Data from [19].
#Data from [23].
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in infertile patients and (ii) that varicocelectomy improves
sperm DNA quality in clinical but not in subclinical varic-
ocele patients. Alternative treatments such as microsurgery
should thus be explored for subclinical varicocele patients.
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